A training and service intervention to optimise pharmacist-based treatment for smoking cessatio

Not Applicable

Completed

• Conditions: Specialty: Primary care, Primary sub-specialty: Public Health; UKCRC code/ Disease: Other/ General symptoms and signs; Mental and Behavioural Disorders; Mental and behavioural disorders due to use of tobacco

• Registration Number: ISRCTN16351033
• Lead Sponsor: Queen Mary University of London

Brief Summary

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31110097 results 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35761321/ (added 28/06/2022) 2019 Protocol article in https://doi.org/10.1186/s13063-019-3368-6 (added 10/05/2024)

Detailed Description

Not available

Study Timeline

• Study Start: 2018-04-03
• Study Completion: 2019-08-01
• Last Update Posted: 21 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1272

Inclusion Criteria

NHS SSP eligibility criteria:
1. Current smokers aged 18 and above
2. All types of smoking (cigarettes, cigar, pipe)

Exclusion Criteria

Exclusion criteria for community pharmacies and pharmacy staff:
1. Sites that lack the facilities for secure storage and transfer of the study data
2. Advisors who refuse GCP training

Exclusion criteria for service users who will be part of the study exploring individual participant level outcomes:
1. Non-smokers
2. Unable to understand the STOP study service user information sheet and consent form
3. Unable/unwilling to give written informed consent for STOP study additional data collection procedures for detailed analysis

Note: The risks and benefits of nicotine replacement need to be explained to pregnant or breastfeeding women and to people who have unstable cardiovascular disorders according to usual practice in the NHS Stop Smoking Service. Neither varenicline nor bupropion should be offered to pregnant or breastfeeding women. Varenicline or bupropion may be offered to people with unstable cardiovascular disorders, subject to clinical judgement
https://www.nice.org.uk/guidance/PH10/chapter/1-Key-priorities

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Throughput, defined as number of smokers who join the NHS SSP, attend a treatment session and set a firm quit date i.e. a ‘treated smoker’ (TS)